Ani Pharmaceuticals (ANIP) Earnings
|
Expand Research on ANIP
| Next EPS Date | 8/12/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +24.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/26  |
Q226 | N/A | $2.02 | N/A | N/A | $263.79M | = | N/A | N/A | ||
| 5/8/26 | Q126 | $2.05 | $1.45 | +$0.60 | $237.5M | $213.42M | = |  | | Details | |
| 2/27/26 | Q425 | $2.33 | $1.97 | +$0.36 | $247.06M | $232.37M | = | | | Details | |
| 11/7/25 |
Q325 | N/A | $1.76 | N/A | N/A | $211.92M | = | N/A | N/A | ||
| 8/8/25 |
Q225 | N/A | $1.40 | N/A | N/A | $187.34M | = | N/A | N/A | ||
| 5/9/25 | Q125 | $1.70 | $1.34 | +$0.36 | $197.1M | $179.21M | = | | | Details | |
| 2/28/25 | Q424 | $1.63 | $1.45 | +$0.18 | $190.6M | $175.12M | = | | | Details | |
| 11/8/24 | Q324 | $1.34 | $1.08 | +$0.26 | $148.3M | $143.98M | = | | | Details |
